Abstract:Bone morphogenetic proteins (BMPs) exert an important role in skeletal development, adult bone homeostasis, and fracture healing and have demonstrated clinical utility for bone regeneration. However, BMPs fall short as regenerative agents because high doses need to be used to obtain therapeutic effects. Determining the molecular mechanisms controlling BMP-induced bone formation may lead to the development of more effective BMP-based therapies. To identify kinases mediating BMP-induced osteoblast differentiation, we performed an siRNA screen to find kinases modulating BMP-6-induced alkaline phosphatase (ALP) activity. Surprisingly, although transforming growth factor β (TGF-β) generally is considered to antagonize BMP-induced osteoblast differentiation, C2C12 cells transfected with siRNAs targeting TGF-β receptors displayed reduced BMP-6-induced ALP activity. Furthermore, pharmacologic inhibitors blocking the TGF-β type I receptor impaired BMP-induced ALP activity in KS483 and C2C12 cells and mineralization of KS483 cells. Consistently, costimulation with BMPs and TGF-β further increased expression of osteoblast-specific genes, ALP activity, and mineralization of KS483 cells and primary mesenchymal stem cells compared with BMPs alone. The stimulatory and inhibitory effects of TGF-β were found to depend on timing and duration of the costimulation. TGF-β inhibited BMP-induced activation of a BMP-Smad-dependent luciferase reporter, suggesting that the stimulatory effect of TGF-β is not due to increased BMP-Smad activity. TGF-β also inhibited the BMP-induced expression of the BMP antagonist noggin and prolonged BMP activity. In conclusion, TGF-β, besides acting as an inhibitor, also can, by dampening the noggin-mediated negative-feedback loop, enhance BMP-induced osteoblast differentiation, which might be beneficial in fracture healing.

Silencing of TGF-β signalling by the pseudoreceptor BAMBI

Human BAMBI Cooperates with Smad7 to Inhibit Transforming Growth Factor-β Signaling*

BMP and activin receptor membrane bound inhibitor: BAMBI has multiple roles in gene expression and diseases (Review)

The Pseudoreceptor Bmp And Activin Membrane-Bound Inhibitor Positively Modulates Wnt/Beta-Catenin Signaling

SMAD1/5 Mediates Bone Morphogenetic Protein 2-Induced Up-Regulation of BAMBI Expression in Human Granulosa-Lutein Cells.

BAMBI Elimination Enhances Alternative TGF-β Signaling and Glomerular Dysfunction in Diabetic Mice.

Physical and Functional Interaction of Murine and Xenopus Smad7 with Bone Morphogenetic Protein Receptors and Transforming Growth Factor-β Receptors

Molecular Recognition in Bone Morphogenetic Protein (bmp)/receptor Interaction

Controlling Cell Fate By Bone Morphogenetic Protein Receptors

BAMBI Promotes C2C12 Myogenic Differentiation by Enhancing Wnt/β-Catenin Signaling

Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation

Regulation of TGF-β Superfamily Signaling by Inhibitory Smads

Identification of BMP and Activin Membrane-Bound Inhibitor (BAMBI) As a Potent Negative Regulator of Adipogenesis and Modulator of Autocrine/paracrine Adipogenic Factors.

Opposing Functions of ZEB Proteins in the Regulation of the TGFbeta/BMP Signaling Pathway

BAMBI shuttling between cytosol and membrane is required for skeletal muscle development and regeneration.

BMP-9 Signals Via ALK1 and Inhibits Bfgf-Induced Endothelial Cell Proliferation and VEGF-stimulated Angiogenesis

BAMBI Promotes Porcine Granulosa Cell Steroidogenesis Involving TGF-β Signaling

Transcriptional repression of the transforming growth factor β (TGF-β) Pseudoreceptor BMP and activin membrane-bound inhibitor (BAMBI) by Nuclear Factor κB (NF-κB) p50 enhances TGF-β signaling in hepatic stellate cells.

Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter*

Cloning And Characterization Of A Human Type-Ii Receptor For Bone Morphogenetic Proteins

Repression of Bone Morphogenetic Protein and Activin-inducible Transcription by Evi-1